Chang Rene Wei-Jung, Chuang Shu-Lin, Hsu Chen-Yang, Yen Amy Ming-Fang, Wu Wendy Yi-Ying, Chen Sam Li-Sheng, Fann Jean Ching-Yuan, Tabar Laszlo, Smith Robert A, Duffy Stephen W, Chiu Sherry Yueh-Hsia, Chen Hsiu-Hsi
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City 100, Taiwan.
Department of Medical Research, National Taiwan University Hospital, Taipei City 100, Taiwan.
Cancers (Basel). 2020 Jul 10;12(7):1855. doi: 10.3390/cancers12071855.
The aim was to evaluate how the inter-screening interval affected the performance of screening by mammographic appearances. This was a Swedish retrospective screening cohort study with information on screening history and mammography features in two periods (1977-1985 and 1996-2010). The pre-clinical incidence and the mean sojourn time (MST) for small breast cancer allowing for sensitivity by mammographic appearances were estimated. The percentage of interval cancer against background incidence (I/E ratio) was used to assess the performance of mammography screening by different inter-screening intervals. The sensitivity-adjusted MSTs (in years) were heterogeneous with mammographic features, being longer for powdery and crushed stone-like calcifications (4.26, (95% CI, 3.50-5.26)) and stellate masses (3.76, (95% CI, 3.15-4.53)) but shorter for circular masses (2.65, (95% CI, 2.06-3.55)) in 1996-2010. The similar trends, albeit longer MSTs, were also noted in 1977-1985. The I/E ratios for the stellate type were 23% and 32% for biennial and triennial screening, respectively. The corresponding figures were 32% and 43% for the circular type and 21% and 29% for powdery and crushed stone-like calcifications, respectively. Mammography-featured progressions of small invasive breast cancer provides a new insight into personalized quality assurance, surveillance, treatment and therapy of early-detected breast cancer.
目的是评估筛查间隔时间如何影响乳腺钼靶影像筛查的效果。这是一项瑞典的回顾性筛查队列研究,包含两个时期(1977 - 1985年和1996 - 2010年)的筛查史及乳腺钼靶特征信息。估计了临床前期发病率以及考虑乳腺钼靶影像敏感度的小乳腺癌平均停留时间(MST)。间隔期癌症占背景发病率的百分比(I/E比率)用于评估不同筛查间隔时间下乳腺钼靶筛查的效果。经敏感度调整后的MST(以年为单位)因乳腺钼靶特征而异,在1996 - 2010年,粉末状和碎石样钙化(4.26,(95%可信区间,3.50 - 5.26))以及星芒状肿块(3.76,(95%可信区间,3.15 - 4.53))的MST较长,而圆形肿块的MST较短(2.65,(95%可信区间,2.06 - 3.55))。在1977 - 1985年也观察到了类似趋势,尽管MST更长。对于星芒状类型,两年一次和三年一次筛查的I/E比率分别为23%和32%。圆形类型的相应数字分别为32%和43%,粉末状和碎石样钙化的相应数字分别为21%和29%。小浸润性乳腺癌的乳腺钼靶特征进展为早期发现的乳腺癌的个性化质量保证、监测、治疗和疗法提供了新的见解。